Cite
Goos T, De Sadeleer LJ, Yserbyt J, et al. Defining and predicting progression in non-IPF interstitial lung disease. Respir Med. 2021;189:106626doi: 10.1016/j.rmed.2021.106626.
Goos, T., De Sadeleer, L. J., Yserbyt, J., De Langhe, E., Dubbeldam, A., Verbeken, E. K., Verleden, G. M., Vermant, M., Verschakelen, J., Vos, R., Weynand, B., Verleden, S. E., & Wuyts, W. A. (2021). Defining and predicting progression in non-IPF interstitial lung disease. Respiratory medicine, 189106626. https://doi.org/10.1016/j.rmed.2021.106626
Goos, Tinne, et al. "Defining and predicting progression in non-IPF interstitial lung disease." Respiratory medicine vol. 189 (2021): 106626. doi: https://doi.org/10.1016/j.rmed.2021.106626
Goos T, De Sadeleer LJ, Yserbyt J, De Langhe E, Dubbeldam A, Verbeken EK, Verleden GM, Vermant M, Verschakelen J, Vos R, Weynand B, Verleden SE, Wuyts WA. Defining and predicting progression in non-IPF interstitial lung disease. Respir Med. 2021 Nov-Dec;189:106626. doi: 10.1016/j.rmed.2021.106626. Epub 2021 Oct 01. PMID: 34627007.
Copy
Download .nbib